Interpace Biosciences
Why Robinhood?
You can watch IDXG and buy or sell other stocks, ETFs, and their options commission-free!About IDXG
Interpace Biosciences, Inc. operates as an bioinformatics company, which engages in the development and commercialization of molecular diagnostic test and pathology services. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment; ThyGenX and PathFinderTG which assesses thyroid nodules for risk of malignancy; and ThyraMIR, which assesses thyroid nodules for risk of malignancy utilizing a proprietary gene expression assay.
IDXG Key Statistics
Stock Snapshot
The current Interpace Biosciences(IDXG) stock price is $1.07, with a market capitalization of 40.77M. The stock trades at a price-to-earnings (P/E) ratio of 0.00 and offers a dividend yield of 0.0%.
During the trading session on 2025-12-05, Interpace Biosciences(IDXG) shares reached a daily high of $1.07 and a low of $0.83. At a current price of $1.07, the stock is +28.6% higher than the low and still 0.0% under the high.
Trading activity shows a volume of 8.06K, compared to an average daily volume of 573.44K.
Over the past 52 weeks, Interpace Biosciences(IDXG) stock has traded between a high of $1.12 and a low of $0.38.
Over the past 52 weeks, Interpace Biosciences(IDXG) stock has traded between a high of $1.12 and a low of $0.38.
IDXG News
TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRank...